Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Hyperoncotic Serum Albumin for Severe Head Injury
NCT00152685Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of albumin (human), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Intracranial Pressure. Status: unknown.
02
Drugs
albumin (human)
Beyond the preview
Go deeper on NCT00152685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152685.